Cellectar Biosciences, Inc. (CLRB) Net income 2016–2025
Cellectar Biosciences, Inc. (CLRB) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$21.8MFY2025 · since FY2016: -$6.2M → -$21.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$21.8M | +51.1% |
| FY2024 | -$44.6M | -4.2% |
| FY2023 | -$42.8M | -34.5% |
| FY2022 | -$31.8M | -31.8% |
| FY2021 | -$24.1M | -59.8% |
| FY2020 | -$15.1M | -7.1% |
| FY2019 | -$14.1M | -6.4% |
| FY2018 | -$13.2M | +2.4% |
| FY2017 | -$13.6M | -119.4% |
| FY2016 | -$6.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLRB financial trends
CLRB RevenueCLRB Net marginCLRB Gross profitCLRB Gross marginCLRB Operating incomeCLRB Operating marginCLRB Operating cash flowCLRB Free cash flowCLRB Capital expendituresCLRB Return on equityCLRB Stock buybacksCLRB Dividends paidCLRB Total assetsCLRB Total liabilitiesCLRB Shareholders’ equityCLRB overview →